CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.

Eli Lilly LLY and AbbVie ABBV are U.S.-based pharmaceutical powerhouses with blockbuster drug portfolios, robust pipelines, ...

The healthcare sector is dominated by massive players, but few are as influential as UnitedHealth Group Incorporated UNH and ...

CVS Health CVS has seen its stock surge by 53.7% in 2025, fueled by a potent combination of strong operational performance ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

CVS Caremark has been the PBM for the plan since Jan. 1, 2017. ... the plan estimated it received a 40% rebate from Novo Nordisk, the manufacturer of GLP-1s Wegovy and Saxenda.

CVS Caremark has been the PBM for the plan since Jan. 1, 2017. ... the plan estimated it received a 40% rebate from Novo Nordisk, the manufacturer of GLP-1s Wegovy and Saxenda.

Earlier this month, Novo announced that CVS Caremark chose Wegovy to be its preferred GLP-1 medication for obesity and weight-loss. 2 This policy will go into effect at the start of July. In a press ...

CVS Caremark, a large pharmacy-benefit manager, this month negotiated a deal with Novo Nordisk to get a discount on the drugmaker’s Wegovy in exchange for making it the preferred option on its ...

CVS Caremark, a large pharmacy-benefit manager, this month negotiated a deal with Novo Nordisk to get a discount on the drugmaker’s Wegovy in exchange for making it the preferred option on its ...